搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Human Putative golgin subfamily A member 6-like protein 4 (GOLGA6L4) CSB-YP405351HU
CSB-EP405351HU
CSB-BP405351HU
CSB-MP405351HU
CSB-EP405351HU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human Putative uncharacterized protein C5orf60 (C5orf60), partial CSB-YP405352HU1
CSB-EP405352HU1
CSB-BP405352HU1
CSB-MP405352HU1
CSB-EP405352HU1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase-like protein MGAT4D (MGAT4D), partial CSB-YP405353HU
CSB-EP405353HU
CSB-BP405353HU
CSB-MP405353HU
CSB-EP405353HU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human Putative PRAME family member 25 (PRAMEF25) CSB-YP405354HU
CSB-EP405354HU
CSB-BP405354HU
CSB-MP405354HU
CSB-EP405354HU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human Putative speedy protein E2-like protein (SPDYE2L) CSB-YP405355HU
CSB-EP405355HU
CSB-BP405355HU
CSB-MP405355HU
CSB-EP405355HU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Brucella ovis Putative Holliday junction resolvase (BOV_A0563) CSB-YP405356BPI
CSB-EP405356BPI
CSB-BP405356BPI
CSB-MP405356BPI
CSB-EP405356BPI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Brucella ovis Putative nickel-responsive regulator (BOV_A0755) CSB-YP405357BPI
CSB-EP405357BPI
CSB-BP405357BPI
CSB-MP405357BPI
CSB-EP405357BPI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Brucella ovis Fructose-1,6-bisphosphatase class 1 (fbp) CSB-YP405358BPI
CSB-EP405358BPI
CSB-BP405358BPI
CSB-MP405358BPI
CSB-EP405358BPI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Brucella ovis D-amino acid dehydrogenase small subunit (dadA) CSB-YP405359BPI
CSB-EP405359BPI
CSB-BP405359BPI
CSB-MP405359BPI
CSB-EP405359BPI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Brucella ovis D-aminopeptidase (dap), partial CSB-YP405360BPI
CSB-EP405360BPI
CSB-BP405360BPI
CSB-MP405360BPI
CSB-EP405360BPI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Brucella ovis 2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-succinyltransferase (dapD) CSB-YP405361BPI
CSB-EP405361BPI
CSB-BP405361BPI
CSB-MP405361BPI
CSB-EP405361BPI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Brucella ovis Flagellar transcriptional regulator ftcR (ftcR) CSB-YP405362BPI
CSB-EP405362BPI
CSB-BP405362BPI
CSB-MP405362BPI
CSB-EP405362BPI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas putida Glycine--tRNA ligase alpha subunit (glyQ) CSB-YP405363PZN
CSB-EP405363PZN
CSB-BP405363PZN
CSB-MP405363PZN
CSB-EP405363PZN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas putida Protoheme IX farnesyltransferase 1 (cyoE1), partial CSB-YP405364PZN
CSB-EP405364PZN
CSB-BP405364PZN
CSB-MP405364PZN
CSB-EP405364PZN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas putida 1- (5-phosphoribosyl)-5-[ (5-phosphoribosylamino)methylideneamino] imidazole-4-carboxamide isomerase CSB-YP405365PZN
CSB-EP405365PZN
CSB-BP405365PZN
CSB-MP405365PZN
CSB-EP405365PZN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas putida Glycerol-3-phosphate acyltransferase (plsY), partial CSB-YP405366PZN1
CSB-EP405366PZN1
CSB-BP405366PZN1
CSB-MP405366PZN1
CSB-EP405366PZN1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas putida Type III pantothenate kinase (coaX) CSB-YP405367PZN
CSB-EP405367PZN
CSB-BP405367PZN
CSB-MP405367PZN
CSB-EP405367PZN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas putida 30S ribosomal protein S7 (rpsG) CSB-YP405368PZN
CSB-EP405368PZN
CSB-BP405368PZN
CSB-MP405368PZN
CSB-EP405368PZN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas putida 50S ribosomal protein L14 (rplN) CSB-YP405369PZN
CSB-EP405369PZN
CSB-BP405369PZN
CSB-MP405369PZN
CSB-EP405369PZN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas putida 30S ribosomal protein S8 (rpsH) CSB-YP405370PZN
CSB-EP405370PZN
CSB-BP405370PZN
CSB-MP405370PZN
CSB-EP405370PZN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>